Guo, Q., He, J., Shen, F., Zhang, W., Yang, X., Zhang, C., . . . Dai, S. (2017). TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma in vitro and in vivo. Oncol Lett.

Guo, Qing, et al. "TCN, an AKT Inhibitor, Exhibits Potent Antitumor Activity and Enhances Radiosensitivity in Hypoxic Esophageal Squamous Cell Carcinoma in Vitro and in Vivo." Oncol Lett 2017.

Guo, Qing, et al. "TCN, an AKT Inhibitor, Exhibits Potent Antitumor Activity and Enhances Radiosensitivity in Hypoxic Esophageal Squamous Cell Carcinoma in Vitro and in Vivo." Oncol Lett 2017.